Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00540852 · ClinicalTrials.gov registry record · NA
Monitoring the Response of Chemotherapy on Breast Cancer Tumor by Photon Migration Spectroscopy
A NA study, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT00540852 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 77 participants.
The verdict
NCT00540852, a NA study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
Optimal management of patients with locally advanced breast cancer remains a complex therapeutic problem. Newly diagnosed breast cancers in the United States with a higher incidence in medically underserved areas. The optimal intensity and duration of neoadjuvant chemotherapy still remains controversial due to the difficulty of evaluating response to therapy. The goal would be to prevent over and under treatment of patients with neoadjuvant chemotherapy.
Interventions
- DEVICE Diffuse Optical Spectroscopy Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2002-06 |
| Est. Completion | 2011-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00540852
The ClinicalTrials.gov registry entry for NCT00540852 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diffuse Optical Spectroscopy Imaging is the first listed.
NCT00540852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00540852 about?
NCT00540852 is a clinical study titled "Monitoring the Response of Chemotherapy on Breast Cancer Tumor by Photon Migration Spectroscopy". Optimal management of patients with locally advanced breast cancer remains a complex therapeutic problem. Newly diagnosed breast cancers in the United States with a higher incidence in medically underserved areas. The optimal intensity and duration of neoadjuvant chemotherapy still remains controver...
What is the current status of trial NCT00540852?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2002-06. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00540852?
The interventions under investigation include: Diffuse Optical Spectroscopy Imaging (DEVICE).
Who is sponsoring clinical trial NCT00540852?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.